“Outcome of Solifenacin Monotherapy and Combined Solifenacin and Mirabegron Therapy in Patient with Overactive Bladder”, J. Com. Med. Col. Teachers Asso., vol. 28, no. 2, pp. 75–81, Dec. 2024, doi: 10.3329/jcomcta.v28i2.78017.